Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. neuropsychopharmacology 
3. original article 
4. article
•  Original Article
•  Published: 19 January 2005
Clinical Research


Association of BDNF Serum
Concentrations with Central
Serotonergic Activity: Evidence
from Auditory Signal
Processing
•  Undine E Lang1,
•  Rainer Hellweg2 &
•  Jürgen Gallinat
3 
Neuropsychopharmacology volume 30, pages 1148–1153 (2005)Cite
this article
•  1347 Accesses
•  40 Citations
•  6 Altmetric
•  Metrics details
Abstract
Disturbances of serotonergic neurotransmission in the brain have
been implicated in the pathogenesis and maintenance of several
psychiatric disorders. According to recent preclinical and clinical
studies, the loudness dependence of auditory evoked potentials (LD)
is related to the central serotonergic neurotransmission in humans.
As the serotonergic phenotype has been reported to be associated
with brain-derived neurotrophic factor (BDNF), we studied whether
BDNF serum concentrations are related to LD in 109 healthy human
volunteers (62 male, 47 female, age: 42.5±13.1 years). Pearson
correlation showed a significant negative correlation between the
BDNF serum concentrations and the LD measured at Fz (r=−0.259,


p=0.007) and a trend for the Cz electrode (r=−0.185, p=0.055).
Although this association needs to be replicated, the results are in
line with the assumption that low serum BDNF levels reflect low
central serotonergic neurotransmission as indicated by a strong LD.
Similar content being viewed by others
[image]
The effects of interval training on peripheral brain
derived neurotrophic factor (BDNF) in young adults: a
systematic review and meta-analysis
Article Open access 26 April 2021
[image]
Chronic BDNF simultaneously inhibits and unmasks
superficial dorsal horn neuronal activity
Article Open access 26 January 2021
[image]
BDNF, proBDNF and IGF-1 serum levels in naïve and
medicated subjects with autism
Article Open access 12 August 2022
Log in or create a free account to read this
content
Gain free access to this article, as well as selected content from this
journal and more on nature.com
 Access through your institution
or


 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
References
•  Altar CA (1999). Neurotrophins and depression. Trends
Pharmacol Sci 20: 59–61.
Article  CAS  Google Scholar 
•  Altar CA, Boylan C, Fritsche M, Jackson C, Hyman C, Lindsay
RM (1994). The neurotrophins NT-4/5 and BDNF augment
serotonin, dopamine, and GABAergic systems during
behaviorally effective infusions to the substantia nigra. Exp
Neurol 130: 31–40.
Article  CAS  Google Scholar 
•  Biver F, Wikler D, Lotstra F, Dambaut P, Goldman S,
Mendlewicz J (1997). Serotonin 5-HT2 receptor imaging in
major depression: focal changes in orbito-insular cortex. Br J
Psychiatry 171: 444–448.
Article  CAS  Google Scholar 
•  Brocke B, Beauducel A, John R, Debener S, Heilemann H
(2000). Sensation seeking and affective disorders:
characteristics in the intensity dependence of acoustic evoked
potentials. Neuropsychobiology 41: 24–30.
Article  CAS  Google Scholar 
•  Chaouloff F (1994). Influence of physical exercise on 5-HT1A
receptor- and anxiety-related behaviours. Neurosci Lett 176:
226–230.
Article  CAS  Google Scholar 


•  Chaouloff F, Laude D, Guezennec Y, Elghozi JL (1986). Motor
activity increases tryptophan, 5-hydroxyindoleacetic acid, and
homovanillic acid in ventricular cerebrospinal fluid of the
conscious rat. J Neurochem 46: 1313–1316.
Article  CAS  Google Scholar 
•  Cheetham SC, Katona CLE, Horton RW (1991). Post-mortem
studies of neurotransmitter biochemistry in depression and
suicide. In: Horton RW, Katona CLE (eds). Biological Aspects of
Affective Disorders. Academic Press: London, UK. pp 192–221.
Google Scholar 
•  Costa PT, McCrae RR (1992). Revised NEO Personality
Inventory and NEO Five-Factor Inventory, Professional Manual.
Psychological Assessment Resources: Odessa, Fl.
Google Scholar 
•  Dey S, Singh RH, Dey PK (1992). Exercise training:
significance of regional alterations in serotonin metabolism of
rat brain in relation to antidepressant effect of exercise.
Physiol Behav 52: 1095–1099.
Article  CAS  Google Scholar 
•  D'Sa C, Duman RS (2002). Antidepressants and
neuroplasticity. Bipolar Disord 4: 183–194.
Article  CAS  Google Scholar 
•  Duman RS, Heninger GR, Nestler EJ (1997). A molecular and
cellular theory of depression. Arch Gen Psychiatry 54: 597–
606.
Article  CAS  Google Scholar 
•  Eaton MJ, Staley JK, Globus MYT, Whittemore SR (1995).
Developmental regulation of early serotonergic neuronal
differentiation: the role of brain-derived neurotrophic factor
and membrane depolarization. Dev Biol 170: 169–182.


Article  CAS  Google Scholar 
•  Friedman J, Meares R (1979). The effect of placebo and
tricyclic antidepressants on cortical evoked potentials in
depressed patients. Biol Psychol 8: 291–302.
Article  CAS  Google Scholar 
•  Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T,
Kambayashi J et al (2002). Brain-derived neurotrophic factor
is stored in human platelets and released by agonist
stimulation. Thromb Haemost 87: 728–734.
Article  CAS  Google Scholar 
•  Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G,
Kuss HJ et al (2000). The loudness dependency of the
auditory evoked N1/P2-component as a predictor of the acute
SSRI response in depression. Psychopharmacology 148: 404–
411.
Article  CAS  Google Scholar 
•  Gallinat J, Mulert C, Bajbouj M, Herrmann WM, Schunter J,
Senkowski D et al (2002). Frontal and temporal dysfunction
of auditory stimulus processing in schizophrenia. Neuroimage
17: 110–127.
Article  Google Scholar 
•  Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I,
Sander T et al (2003). Allelic variants of the functional
promoter polymorphism of the human serotonin transporter
gene is associated with auditory cortical stimulus processing.
Neuropsychopharmacology 28: 530–532.
Article  CAS  Google Scholar 
•  Garza AA, Ha TG, Garcia C, Chen MJ, Russo-Neustadt AA
(2004). Exercise, antidepressant treatment, and BDNF mRNA
expression in the aging brain. Pharmacol Biochem Behav 77:
209–220.


Article  CAS  Google Scholar 
•  Gjerris A (1988). Baseline studies on transmitter substances in
cerebrospinal fluid in depression. Acta Psychiatr Scand Suppl
346: 1–35.
Article  CAS  Google Scholar 
•  Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B,
Newman ME (2002). Functional effects of chronic
electroconvulsive shock on serotonergic 5-HT(1A) and 5-
HT(1B) receptor activity in rat hippocampus and
hypothalamus. Brain Res 952: 52–60.
Article  CAS  Google Scholar 
•  Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M,
Moller HJ (1998). The serotonin syndrome scale: first results
on validity. Eur Arch Psychiatry Clin Neurosci 248: 96–103.
Article  CAS  Google Scholar 
•  Hegerl U, Juckel G (1993). Intensity dependence of auditory
evoked potentials as an indicator of central serotonergic
neurotransmission: a new hypothesis. Biol Psychiatry 33: 173–
187.
Article  CAS  Google Scholar 
•  Hegerl U, Juckel G, Rao ML, Müller-Oerlinghausen B (1991).
Blood serotonin and auditory evoked potentials under
fluvoxamine challenge and phototherapy. In: Cassano GB,
Akiskal HS (eds). Serotonin-Related Psychiatric Syndromes:
Clinical and Therapeutic Links. Royal Society of Medicine
Services Limited: New York. pp 163–170.
Google Scholar 
•  Heinz A, Mann K, Weinberger DR, Goldman D (2001).
Serotonergic dysfunction, negative mood states, and response
to alcohol. Alcohol Clin Exp Res 25: 487–495.


Article  CAS  Google Scholar 
•  Hellweg R, Hock C, Hartung HD (1989). An improved rapid
and highly sensitive enzyme immunoassay for nerve growth
factor. J Methods Cell Mol Biol 1: 43–49.
Google Scholar 
•  Hellweg R, von Armin CAF, Büchner M, Huber R, Riepe MW
(2003). Neuroprotection and neuronal dysfunction upon
repetitive disinhibition of oxidative phosphorylation. Exp
Neurol 183: 346–354.
Article  CAS  Google Scholar 
•  Herrmann MJ, Sonnek G, Weijers HG, Wiesbeck GA, Boning
J, Fallgatter AJ (2002). Electrophysiological indication for a
link between serotonergic neurotransmission and personality
in alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 26:
157–161.
Article  CAS  Google Scholar 
•  Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G (1999).
Auditory evoked potentials reflect serotonergic neuronal
activity—a study in behaving cats administered drugs acting
on 5-HT1A autoreceptors in the dorsal raphe nucleus.
Neuropsychopharmacology 21: 710–716.
Article  CAS  Google Scholar 
•  Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G (1997).
Auditory evoked potentials as indicators of brain serotonergic
activity—first evidence in cats. Biol Psychiatry 41: 1181–1195.
Article  CAS  Google Scholar 
•  Karege F, Schwald M, Cisse M (2002). Postnatal
developmental profile of brain-derived neurotrophic factor in
rat brain and platelets. Neurosci Lett 328: 261–264.
Article  CAS  Google Scholar 


•  Lang UE, Hellweg R, Gallinat J (2004). BDNF serum
concentrations in healthy humans are associated with
depression-related personality traits.
Neuropsychopharmacology 29: 795–798.
Article  CAS  Google Scholar 
•  Lesch KP, Wolozin BL, Murphy DL, Riederer P (1993).
Primary structure of the human platelet serotonin uptake site:
identity with the brain serotonin transporter. J Neurochem 60:
2319–2322.
Article  CAS  Google Scholar 
•  Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH,
Carpenter L et al (1998). Reduced brain serotonin transporter
availability in major depression as measured by [123I]-2
beta-carbomethoxy-3-beta-(4-iodophenyl)tropane and single
photon emission computed tomography. Biol Psychiatry 44:
1090–1098.
Article  CAS  Google Scholar 
•  Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L,
Lyons WE (2000). BDNF promotes the regenerative sprouting,
but not survival, of injured serotoninergic axons in the adult
rat brain. J Neurosci 20: 771–782.
Article  CAS  Google Scholar 
•  Mamounas LA, Blue ME, Siuciak JA, Altar CA (1995). Brain-
derived neurotrophic factor promotes the survival and
sprouting of serotonergic axons in rat brain. J Neurosci 15:
7929–7939.
Article  CAS  Google Scholar 
•  Manjarrez GG, Hernandez ZE, Robles OA, Gonzalez RM,
Hernandez RJ (2001). Developmental impairment of auditory
evoked N1/P2 component in rats undernourished in utero: its
relation to brain serotonin activity. Brain Res Dev Brain Res
127: 149–155.


Article  Google Scholar 
•  Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff KA, Gray N
et al (2003). Enhancing neuronal plasticity and cellular
resilience to develop novel, improved therapeutics for
difficult-to-treat depression. Biol Psychiatry 53: 707–742.
Article  CAS  Google Scholar 
•  Meeusen R, Thorre K, Chaouloff F, Sarre S, De Meirleir K,
Ebinger G et al (1996). Effects of tryptophan and/or acute
running on extracellular 5-HT and 5-HIAA levels in the
hippocampus of food-deprived rats. Brain Res 740: 245–252.
Article  CAS  Google Scholar 
•  Mössner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt
A et al (2000). Serotonin transporter function is modulated by
brain-derived neurotrophic factor (BDNF) but not nerve
growth factor (NGF). Neurochem Int 36: 197–202.
Article  Google Scholar 
•  Nibuya M, Morinobu S, Duman RS (1995). Regulation of
BDNF and trkB mRNA in rat brain by chronic
electroconvulsive seizure and antidepressant drug treatments.
J Neurosci 15: 7539–7547.
Article  CAS  Google Scholar 
•  Owens MJ, Nemeroff CB (1994). Role of serotonin in the
pathophysiology of depression: focus on the serotonin
receptor. Clin Chem 40: 288–295.
PubMed  CAS  Google Scholar 
•  Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998).
Transport of brain-derived neurotrophic factor across the
blood–brain barrier. Neuropsychopharmacol 37: 1553–1561.
CAS  Google Scholar 


•  Pardridge WM (2002). Neurotrophins, neuroprotection and
the blood–brain barrier. Curr Opin Investig Drugs 3: 1753–
1757.
PubMed  CAS  Google Scholar 
•  Pearse AG (1980). The common peptides and the
cytochemistry of their cells of origin. Basic Appl Histochem 24:
63–73.
PubMed  CAS  Google Scholar 
•  Petty F, Davis LL, Kabel D, Kramer GL (1996). Serotonin
dysfunction disorders: a behavioral neurochemistry
perspective. J Clin Psychiatry 57 (Suppl 8): 11–16.
PubMed  Google Scholar 
•  Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N,
Mzengeza S et al (2004). Measurement of brain regional
alpha-[11C]methyl-L-tryptophan trapping as a measure of
serotonin synthesis in medication-free patients with major
depression. Arch Gen Psychiatry 61: 556–563.
Article  CAS  Google Scholar 
•  Rumajogee P, Madeira A, Vergé D, Hamon M, Miquel MC
(2002). Up-regulation of the neuronal serotoninergic
phenotype in vitro: BDNF and cAMP share TrkB-dependent
mechanisms. J Neurochem 83: 1525–1528.
Article  CAS  Google Scholar 
•  Russo-Neustadt A (2003). Brain-derived neurotrophic factor,
behavior, and new directions for the treatment of mental
disorders. Semin Clin Neuropsychiatry 8: 109–118.
Article  Google Scholar 
•  Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW
(2000). Physical activity and antidepressant treatment
potentiate the expression of specific brain-derived


neurotrophic factor transcripts in the rat hippocampus.
Neuroscience 101: 305–312.
Article  CAS  Google Scholar 
•  Schildkraut JJ (1965). The catecholamine hypothesis of
affective disorders: a review of the supporting evidence. Am J
Psychiatry 122: 509–521.
Article  CAS  Google Scholar 
•  Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L,
Chakravarti A et al (2003). A BDNF coding variant is
associated with the NEO personality inventory domain
neuroticism, a risk factor for depression.
Neuropsychopharmacology 28: 397–401.
Article  CAS  Google Scholar 
•  Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J,
Gleiberman L et al (2004). Serotonin transporter and GABAA
alpha 6 receptor variants are associated with neuroticism. Biol
Psychiatry 55: 244–249.
Article  CAS  Google Scholar 
•  Senkowski D, Linden M, Zubrägel D, Bär T, Gallinat J (2003).
Evidence for disturbed cortical signal processing and altered
serotonergic neurotransmission in generalized anxiety
disorder. Biol Psychiatry 53: 304–314.
Article  CAS  Google Scholar 
•  Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J,
Weiller E (1998). The Mini-International Neuropsychiatric
Interview (M.I.N.I.): the development and validation of a
structured diagnostic psychiatric interview for DSM-IV and
ICD-10. J Clin Psychiatry 59: 22–33.
PubMed  Google Scholar 
•  Shen H, Numachi Y, Yoshida S, Toda S, Awata S, Matsuoka H


et al (2001). Electroconvulsive shock regulates serotonin
transporter mRNA expression in rat raphe nucleus. Psychiatry
Clin Neurosci 55: 75–77.
Article  CAS  Google Scholar 
•  Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS
(2002). Brain-derived neurotrophic factor produces
antidepressant effects in behavioral models of depression. J
Neurosci 22: 3251–3261.
Article  CAS  Google Scholar 
•  Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM
(1996). BDNF increases monoaminergic activity in rat brain
following intracerebroventricular or intraparenchymal
administration. Brain Res 710: 11–20.
Article  CAS  Google Scholar 
•  Siuciak JA, Clark MS, Rind HB, Whettemore SR, Russo AF
(1998). BDNF induction of tryptophan hydroxylase mRNA
levels in the rat brain. J Neurosci Res 52: 149–158.
Article  CAS  Google Scholar 
•  Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997).
Antidepressant-like effect of brain-derived neurotrophic factor
(BDNF). Pharmacol Biochem Behav 56: 131–137.
Article  CAS  Google Scholar 
•  Stanley M, Mann JJ (1983). Increased serotonin-2 binding
sites in frontal cortex of suicide victims. Lancet 1: 214–216.
Article  CAS  Google Scholar 
•  Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S,
Pelz S et al (2000). High intensity dependence of auditory
evoked dipole source activity indicates decreased serotonergic
activity in abstinent ecstasy (MDMA) users.
Neuropsychopharmacology 22: 608–617.


Article  CAS  Google Scholar 
•  von Knorring L, Perris C (1981). Biochemistry of the
augmenting-reducing response in visual evoked potentials.
Neuropsychobiology 7: 1–8.
Article  CAS  Google Scholar 
•  Yamamoto H, Gurney ME (1990). Human platelets contain
brain-derived neurotrophic factor. J Neurosci 10: 3469–3478.
Article  CAS  Google Scholar 
•  Yates M, Leake A, Candy JM, Fairbaim AF, McKeith IG,
Ferrier IN (1990). 5HT2 receptor changes in major
depression. Biol Psychiatry 27: 489–496.
Article  CAS  Google Scholar 
Download references
Acknowledgements
We gratefully acknowledge the excellent technical assistance of Mrs
Bunge.
Author information
Authors and Affiliations
1. Department of Neurology, University of Tuebingen,
Tuebingen, Germany
Undine E Lang
2. Clinic for Psychiatry and Psychotherapy, Charité Medicine
Berlin, Campus Benjamin Franklin, Germany


Rainer Hellweg
3. Clinic for Psychiatry and Psychotherapy, Charité Medicine
Berlin, Campus Charité Mitte, Germany
Jürgen Gallinat
Authors
1. Undine E Lang
View author publications
Search author on:PubMed Google Scholar
2. Rainer Hellweg
View author publications
Search author on:PubMed Google Scholar
3. Jürgen Gallinat
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Jürgen Gallinat.
Rights and permissions
Reprints and permissions
About this article
Cite this article
Lang, U., Hellweg, R. & Gallinat, J. Association of BDNF Serum
Concentrations with Central Serotonergic Activity: Evidence from


Auditory Signal Processing. Neuropsychopharmacol 30, 1148–1153
(2005). https://doi.org/10.1038/sj.npp.1300666
Download citation
•  Received: 09 September 2004
•  Revised: 08 November 2004
•  Accepted: 01 December 2004
•  Published: 19 January 2005
•  Issue date: 01 June 2005
•  DOI: https://doi.org/10.1038/sj.npp.1300666
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
•  BDNF
•  brain-derived neurotrophic factor
•  evoked potentials
•  loudness dependence
•  healthy volunteers
•  neuroticism
•  serotonin


This article is cited by
•  Serum brain-derived neurotrophic factor level
and exercise tolerance complement each other in
predicting the prognosis of patients with heart
failure
○  Atsushi Shibata
○  Akihisa Hanatani
○  Minoru Yoshiyama
Heart and Vessels (2018)
•  Chronic modulation of serotonergic
neurotransmission with sertraline attenuates the
loudness dependence of the auditory evoked
potential in healthy participants
○  Julian G. Simmons
○  Pradeep J. Nathan
○  Nicholas B. Allen
Psychopharmacology (2011)
•  Loudness dependence of auditory evoked
potentials (LDAEP) correlates with the
availability of dopamine transporters and
serotonin transporters in healthy volunteers—a
two isotopes SPECT study
○  I Hui Lee
○  Yen Kuang Yang
○  Shih-Hsien Lin
Psychopharmacology (2011)
•  Association of the met66 allele of brain-derived
neurotrophic factor (BDNF) with smoking


○  Undine E. Lang
○  Thomas Sander
○  Jürgen Gallinat
Psychopharmacology (2007)
•  Further Evidence for an Association of 5-HTTLPR
with Intensity Dependence of Auditory-Evoked
Potentials
○  Tilman Hensch
○  Hanna-Linn Wargelius
○  Burkhard Brocke
Neuropsychopharmacology (2006)
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Podcasts
•  Current issue
•  Collections
•  Follow us on Facebook
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed


About the journal
•  Journal Information
•  Open Access Fees and Funding
•  About the Editors
•  Contact
•  Press Releases
•  About the Partner
•  For Advertisers
•  Subscribe
•  Announcements
•  NPP has a new YouTube channel!
•  Latest Press Release
Publish with us
•  For Authors & Referees
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies


Neuropsychopharmacology (Neuropsychopharmacol.)
ISSN 1740-634X (online)
ISSN 0893-133X (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools


•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


